Mariël Brok

1.8k total citations
14 papers, 951 citations indexed

About

Mariël Brok is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Mariël Brok has authored 14 papers receiving a total of 951 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 2 papers in Oncology and 2 papers in Hematology. Recurrent topics in Mariël Brok's work include Fungal and yeast genetics research (5 papers), Genomics and Chromatin Dynamics (5 papers) and DNA Repair Mechanisms (4 papers). Mariël Brok is often cited by papers focused on Fungal and yeast genetics research (5 papers), Genomics and Chromatin Dynamics (5 papers) and DNA Repair Mechanisms (4 papers). Mariël Brok collaborates with scholars based in Netherlands, United States and France. Mariël Brok's co-authors include Kees Nooter, Herman Burger, Erik A.C. Wiemer, Hans van Tol, Antonius W.M. Boersma, G. Stoter, Frank C. P. Holstege, Dik van Leenen, Patrick Kemmeren and Marian J.A. Groot Koerkamp and has published in prestigious journals such as Nucleic Acids Research, Nature Communications and Blood.

In The Last Decade

Mariël Brok

14 papers receiving 946 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mariël Brok Netherlands 13 531 323 232 154 80 14 951
Heriberto Bruzzoni‐Giovanelli France 15 570 1.1× 281 0.9× 179 0.8× 120 0.8× 64 0.8× 23 932
GJ Schuurhuis Netherlands 14 293 0.6× 375 1.2× 240 1.0× 108 0.7× 28 0.3× 18 701
Monica Pallis United Kingdom 23 674 1.3× 509 1.6× 590 2.5× 168 1.1× 34 0.4× 61 1.3k
Carl G. Schmidt Germany 13 349 0.7× 265 0.8× 142 0.6× 98 0.6× 84 1.1× 33 798
Juraj Bodo United States 17 665 1.3× 354 1.1× 252 1.1× 429 2.8× 58 0.7× 48 1.3k
E.Michael Egan United States 12 815 1.5× 330 1.0× 281 1.2× 111 0.7× 45 0.6× 18 1.2k
Yoko Okitsu Japan 15 320 0.6× 198 0.6× 186 0.8× 110 0.7× 30 0.4× 49 647
Shwu‐Luan Lee United States 6 353 0.7× 118 0.4× 219 0.9× 103 0.7× 30 0.4× 7 655
Nikhil Mukhi United States 7 398 0.7× 367 1.1× 132 0.6× 250 1.6× 71 0.9× 14 891

Countries citing papers authored by Mariël Brok

Since Specialization
Citations

This map shows the geographic impact of Mariël Brok's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mariël Brok with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mariël Brok more than expected).

Fields of papers citing papers by Mariël Brok

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mariël Brok. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mariël Brok. The network helps show where Mariël Brok may publish in the future.

Co-authorship network of co-authors of Mariël Brok

This figure shows the co-authorship network connecting the top 25 collaborators of Mariël Brok. A scholar is included among the top collaborators of Mariël Brok based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mariël Brok. Mariël Brok is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
DeMartino, Jeff, Michael T. Meister, Lindy L. Visser, et al.. (2023). Single-cell transcriptomics reveals immune suppression and cell states predictive of patient outcomes in rhabdomyosarcoma. Nature Communications. 14(1). 3074–3074. 23 indexed citations
2.
Brok, Mariël, et al.. (2020). Genome‐wide off‐rates reveal how DNA binding dynamics shape transcription factor function. Molecular Systems Biology. 16(10). e9885–e9885. 12 indexed citations
3.
Brok, Mariël, et al.. (2020). An Optimized Chromatin Immunoprecipitation Protocol for Quantification of Protein-DNA Interactions. STAR Protocols. 1(1). 100020–100020. 13 indexed citations
4.
Sameith, Katrin, Marian J.A. Groot Koerkamp, Dik van Leenen, et al.. (2015). A high-resolution gene expression atlas of epistasis between gene-specific transcription factors exposes potential mechanisms for genetic interactions. BMC Biology. 13(1). 112–112. 15 indexed citations
5.
O’Duibhir, Eoghan, Philip Lijnzaad, Joris J. Benschop, et al.. (2014). Cell cycle population effects in perturbation studies. Molecular Systems Biology. 10(6). 732–732. 84 indexed citations
6.
Snoeren, Nikol, Sander R. van Hooff, René Adam, et al.. (2012). Exploring Gene Expression Signatures for Predicting Disease Free Survival after Resection of Colorectal Cancer Liver Metastases. PLoS ONE. 7(11). e49442–e49442. 15 indexed citations
7.
Lenstra, Tineke L., Joris J. Benschop, Tae Soo Kim, et al.. (2011). The Specificity and Topology of Chromatin Interaction Pathways in Yeast. Molecular Cell. 42(4). 536–549. 181 indexed citations
8.
Bakel, Harm van, Folkert J. van Werven, Marijana Radonjić, et al.. (2008). Improved genome-wide localization by ChIP-chip using double-round T7 RNA polymerase-based amplification. Nucleic Acids Research. 36(4). e21–e21. 36 indexed citations
9.
Burger, Herman, Hans van Tol, Mariël Brok, et al.. (2005). Chronic imatinib mesylate exposure leads to reduced intracellular drug accumulation by induction of the ABCG2 (BCRP) and ABCB1 (MDR1) drug transport pumps. Cancer Biology & Therapy. 4(7). 747–752. 159 indexed citations
10.
Burger, Herman, Hans van Tol, Antonius W.M. Boersma, et al.. (2004). Imatinib mesylate (STI571) is a substrate for the breast cancer resistance protein (BCRP)/ABCG2 drug pump. Blood. 104(9). 2940–2942. 333 indexed citations
11.
Schenk, Paul W., Mariël Brok, Antonius W.M. Boersma, et al.. (2003). Anticancer Drug Resistance Induced by Disruption of the Saccharomyces cerevisiae NPR2 Gene: a Novel Component Involved in Cisplatin- and Doxorubicin-Provoked Cell Kill. Molecular Pharmacology. 64(2). 259–268. 42 indexed citations
12.
Verhagen, Paul C.M.S., Karin G. Hermans, Mariël Brok, et al.. (2002). Deletion of chromosomal region 6q14‐16 in prostate cancer. International Journal of Cancer. 102(2). 142–147. 21 indexed citations
13.
Schenk, Paul W., Antonius W.M. Boersma, Mariël Brok, et al.. (2002). Inactivation of the Saccharomyces cerevisiae SKY1Gene Induces a Specific Modification of the Yeast Anticancer Drug Sensitivity Profile Accompanied by a Mutator Phenotype. Molecular Pharmacology. 61(3). 659–666. 2 indexed citations
14.
Schenk, Paul W., Antonius W.M. Boersma, Mariël Brok, et al.. (2002). Inactivation of theSaccharomyces cerevisiae SKY1Gene Induces a Specific Modification of the Yeast Anticancer Drug Sensitivity Profile Accompanied by a Mutator Phenotype. Molecular Pharmacology. 61(3). 659–666. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026